Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content
Fig. 3 | Alzheimer's Research & Therapy

Fig. 3

From: HCN2 deficiency correlates with memory deficits and hyperexcitability of dCA1 pyramidal neurons in Alzheimer’s disease

Fig. 3

Disrupted functions of HCNs in dCA1 PNs of hAPP-J20 mice or in dCA1 PNs of WT mice treated with oligomeric Aβ. (A) Representative traces elicited by a series of negative current injections of dCA1 PNs in WT and hAPP-J20 mice. (B) The sag ratio at the − 200 pA current injection detected from the dCA1 PNs of hAPP-J20 and WT mice. Unpaired t-test: t (61) = 2.395, p = 0.0197. (C) Sag amplitudes of dCA1 PNs at − 200 to 0-pA current injections. Two-way ANOVA: genotype (hAPP), F (1, 61) = 31.81, p < 0.0001; current step, F (1.225, 74.71) = 450.0, p < 0.0001; interaction, F (4, 244) = 16.29, p < 0.0001; **p < 0.01, ****p < 0.0001 with Bonferroni’s post-hoc test. (D) Representative traces of the HCN-conducted Ih currents in dCA1 PNs of WT and hAPP-J20 mice. (E) The HCN-conducted Ih currents in dCA1 PNs of hAPP-J20 and WT mice (WT, n = 10 cells from 5 mice; J20, n = 10 cells from 5 mice). Two-way ANOVA: genotype (hAPP), F (1, 18) = 18.04, p = 0.0005; voltage step, F (6, 108) = 124.7, p < 0.0001; interaction, F (6, 108) = 8.998, p < 0.0001; **p < 0.01, ****p < 0.0001 with Bonferroni’s post-hoc test. (F) Representative traces elicited by a series of negative current injections of dCA1 PVs in WT and hAPP-J20 mice. (G) The sag ratio at the − 200 pA current injection detected from the dCA1 PVs of hAPP-J20 and WT mice. Unpaired t-test: t (46) = 1.812, p = 0.0765. (H) The sag amplitudes of PVs from hAPP-J20 and WT mice. Two-way ANOVA: genotype (hAPP), F (1, 46) = 2.134, p = 0.1508; current step, F (1.025, 47.16) = 243.4, p < 0.0001; interaction, F (4, 184) = 0.7310, p = 0.5719. (I) Representative traces of the HCN-conducted Ih currents in dCA1 PVs of WT and hAPP-J20 mice. (J) The HCN-conducted Ih currents of dCA1 PVs of hAPP-J20 and WT mice (WT, n = 23 cells from 9 mice; J20, n = 25 cells from 10 mice). Two-way ANOVA: genotype (hAPP), F (1, 23) = 0.005643, p = 0.9408; voltage step, F (2.001, 46.03) = 224.3, p < 0.0001; interaction, F (6, 138) = 0.3319, p = 0.9192. (K) Representative bands showing the Aβ oligomers by western blotting with 6E10. (L) Representative traces of the HCN-conducted Ih currents in dCA1 PNs of WT mice sampled from baseline, Aβ oligomers (10 nM) and Aβ + cAMP treatment, respectively. (M) Quantification of the Ih currents in dCA1 PNs from the three groups in (L) (baseline, n = 15 cells from 5 mice; Aβ, n = 15 cells from 5 mice; Aβ + cAMP, n = 14 cells from 5 mice). Two-way ANOVA with Bonferroni’s post-hoc test: drug, F (2, 41) = 5.383, p = 0.0084; voltage step, F (6, 246) = 506.2, p < 0.0001; interaction, F (12, 246) = 3.875, p < 0.0001

Back to article page